Probiotics use is associated with improved clinical outcomes among hospitalized patients with COVID-19

BACKGROUND AND AIMS: Currently, there are no definitive therapies for coronavirus disease 2019 (COVID-19). Gut microbial dysbiosis has been proved to be associated with COVID-19 severity and probiotics is an adjunctive therapy for COIVD-19. However, the potential benefit of probiotics in COVID-19 ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Lina, Han, Huanqin, Li, Xuan, Chen, Caozhen, Xie, Xiaobing, Su, Guomei, Ye, Shicai, Wang, Cuili, He, Qing, Wang, Fang, Huang, Fang, Wang, Zhaoqin, Wu, Jiayuan, Lai, Tianwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351028/
https://www.ncbi.nlm.nih.gov/pubmed/34394726
http://dx.doi.org/10.1177/17562848211035670

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351028/
https://www.ncbi.nlm.nih.gov/pubmed/34394726
http://dx.doi.org/10.1177/17562848211035670

Ejemplares similares